AKT1 and B-cell chronic lymphocytic leukemia: These latter findings help to explain the in vitro capacity of the drug to induce apoptosis since both AKT activation status and levels of the anti-apoptotic proteins Mcl-1 and XIAP are known to play key roles in apoptosis status of CLL B-cells [25, 26].